GO
Loading...
Live at 2:30p ET
LINDSEY VONN
CNBC.com web-only interview
Downhill skier Lindsay Vonn

NPS Pharmaceuticals CEO on Gattex's FDA Approval

Monday, 7 Jan 2013 | 6:15 PM ET

NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.